Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis ; volume:19 ; number:1 ; day:30 ; month:12 ; year:2019 ; pages:1-4 ; date:12.2019
BMC ophthalmology ; 19, Heft 1 (30.12.2019), 1-4, 12.2019
- Creator
-
Shinkai, Akihiro
Saito, Wataru
Hashimoto, Yuki
Ishida, Susumu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-019-1280-1
- URN
-
urn:nbn:de:101:1-2020041022383195942820
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shinkai, Akihiro
- Saito, Wataru
- Hashimoto, Yuki
- Ishida, Susumu
- SpringerLink (Online service)
Other Objects (12)
Etiology of idiopathic macular holes in the light of estrogen hormone
Macular Structure Recovery after Surgery for Optic Disc Pit Maculopathy
Anti-VEGF for the management of diabetic macular edema
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-retinal autoantibodies in myopic macular degeneration: a pilot study
ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Macular edema
Estrogen rescues heart failure through estrogen receptor Beta activation
The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema
Patient Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Etiology of idiopathic macular holes in the light of estrogen hormone
Macular Structure Recovery after Surgery for Optic Disc Pit Maculopathy
Anti-VEGF for the management of diabetic macular edema
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-retinal autoantibodies in myopic macular degeneration: a pilot study
ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Macular edema
Estrogen rescues heart failure through estrogen receptor Beta activation
The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema
Patient Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Etiology of idiopathic macular holes in the light of estrogen hormone
Macular Structure Recovery after Surgery for Optic Disc Pit Maculopathy
Anti-VEGF for the management of diabetic macular edema
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-retinal autoantibodies in myopic macular degeneration: a pilot study
ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Macular edema
Estrogen rescues heart failure through estrogen receptor Beta activation
The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema